Karl landsteiner and his major contributions to haematology
Open accessThe DOI matches its Crossref record.
Abstract
Karl Landsteiner was born in Vienna in 1868. He graduated from the Vienna Medical School in 1891, which dominated one of his most productive and formative periods in the following years. Although he devoted himself to research in bacteriology, haematology and immunology, he tried to maintain a close relationship with clinical medicine. Landsteiner's intellectual curiosity was centred on fundamental questions about the specificity of antisera directed against various antigens. His research with chemically modified proteins also led to the concept of the specificity of serological reactions, defined in his classical book on this subject. The attachment of small organic molecules to proteins, which in 1921 he called ‘haptens’, was the foundation for future immunological research into the nature of antibody-combining sites, antigenic determinants and antibody–antigen binding forces. In 1930, Landsteiner was awarded the Nobel Prize for his description of the human ABO blood group system, which he himself considered an accidental discovery. Karl Landsteiner discovered human blood groups in 1900 and laid the foundation for the modern medical practice of blood transfusion. The ABO blood groups have a role in physiology beyond their importance for blood transfusion. In the past few years, red cell antigens (A and B carbohydrate structures) have been found on a variety of cells, tissues and proteins, indicating that these antigens might be involved in different physiological processes. The blood group O has an edge in Darwin's concept of the survival of the fittest because it confers protection from vascular diseases. Many studies have established a relationship between the ABO blood groups and the risk of coronary heart disease, atherosclerosis and venous thrombosis (Souto et al, 2000). Hypercoagulation is a risk factor for vascular diseases. It can be caused by excessive concentrations of proteins whose function is to maintain haemostasis. Such proteins include factor VIII (FVIII) and von Willebrand factor (VWF). Lower concentrations of VWF and FVIII are found in the circulation of people who have blood group O than in those with blood group A, B or AB (Souto et al, 2000). The mean VWF antigen concentration is 25% lower in blood group O than in other blood groups (Moeller et al, 2001; O'Donell & Laffan, 2001). This often leads to diagnostic difficulties in distinguishing mild forms of the inherited bleeding disorder, type I von Willebrand's Disease (VWD), from a healthy blood group O (Nitu-Whalley et al, 2000). Plasma phenotypes differ between OO and non-OO genotypes. Recently a link was found between the ABO gene locus and the VWF antigen concentration, and one was suggested between the ABO gene locus and FVIII coagulation activity (Souto et al, 2000). Blood groups influence the VWF antigen level not only in normal subjects but also in heterozygous VWF-deficient subjects who have a null allele with certain missense mutations in the VWF gene. The heterogeneity of plasma phenotypes in heterozygous carriers for type 3 VWD might be due to blood groups (Castaman & Elkenboom, 2002). Von Willebrand factor is a large multimeric glycoprotein that is synthesized in endothelial cells and megakaryocytes. It has a dual role in haemostasis. In primary haemostasis, VWF is essential for the adhesion of platelets to sites of vascular injury. In its second role, VWF is crucial to intrinsic coagulation because it binds to the amino-terminal part of FVIII and preserves it in the circulation (Schwarz et al, 2002). Mature VWF is heavily glycosylated, containing 12 ASN-linked 10 Ser/Thr-linked oligosaccharide chains. The N-linked oligosaccharide chains contain the ABO blood group antigens (Matsui et al, 1993; Sarode et al, 2000). Studies on ABO-mismatched bone marrow transplantations indicate that platelet-derived VWF synthesized in megakaryocytes does not contain these blood group antigens in contrast to the endothelial-cell-synthesized VWF found in plasma (Matsui et al, 1999). The only other known plasma proteins that contain ASN-linked ABO blood group antigens are alpha 2 macroglobulin and FVIII (Matsui et al, 1993). The biological function of blood group antigens on VWF and FVIII is still not clear but blood group sugar chains might influence the functional properties of VWF such as ristocetin-induced platelet agglutination or the metabolic clearance of VWF and its susceptibility to proteolysis (Sarode et al, 2000). The first description of the congenital dysfunctional state of VWF in causing bleeding was published by Erik von Willebrand (von Willebrand, 1931), 1 year after Karl Landsteiner was awarded the Nobel Prize in Physiology or Medicine for the discovery of human blood groups. In his 17th publication, a 1·5 page communication in the Wiener Klinische Wochenschrift (the organ of the Royal and Imperial Society of Physicians in Vienna), which appeared on 14 November 1901, Karl Landsteiner classified blood into three groups accord
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Protein Glycosylation in Cancer
Stowell, S. R., Ju, T., & Cummings, R. D. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040438 · Cited by 873
Chemical Biology of the Sugar Code
Gabius, H., Siebert, H., André, S., Jiménez‐Barbero, J., & Rüdiger, H. (2004) · ChemBioChem · doi:10.1002/cbic.200300753 · Cited by 524
Solís, D., Bovin, N. V., Davis, A. P., Jiménez-Barbero, J., Romero, A., Roy, R., Smetana, K., & Gabius, H.-J. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.03.016 · Cited by 222
Jajosky, R. P., Wu, S.-C., Zheng, L., Jajosky, A. N., Jajosky, P. G., Josephson, C. D., Hollenhorst, M. A., Sackstein, R., Cummings, R. D., Arthur, C. M., et al. (2023) · iScience · doi:10.1016/j.isci.2022.105798 · Cited by 110
Sweet complementarity: the functional pairing of glycans with lectins
Gabius, H.-J., Manning, J. C., Kopitz, J., André, S., & Kaltner, H. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2163-8 · Cited by 74
Metadata
- Authors
- Schwarz, H. P., & Dorner, F.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2003-05
- Volume
- 121
- Issue
- 4
- Pages
- 556-565
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2010086153
- Cited by
- 89
- References
- 0
- FWCI
- 26.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Karl landsteiner and his major contributions to haematology. https://app.cochat.ai/papers/10.1046/j.1365-2141.2003.04295.x
- The paper
- Schwarz, H. P., & Dorner, F. (2003). Karl landsteiner and his major contributions to haematology. British Journal of Haematology. https://doi.org/10.1046/j.1365-2141.2003.04295.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.